The recommended dosage of Nereus is 85mg or 170mg as a single oral dose approximately 60 minutes before an event expected to cause vomiting induced by motion. Nereus ™ (tradipitant) is now available ...
Vanda Pharmaceuticals Inc. (Vanda), a leading global biopharmaceutical company, announced that Nereus (tradipitant) is now commercially available across the United States for the prevention of ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min It's the first new prescription ...
The FDA's usual end-of-year flurry of regulatory approvals is a little lighter than usual, but the agency has delivered some end-of-year cheer to Vanda Pharma after giving the go-ahead to its drug for ...
The Navarro family was well known in Texas even before José Antonio Navarro played a key role in the Texas revolution. Learn about members of this socially and politically prominent San Antonio family ...
WASHINGTON, May 1, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that NEREUS™ (tradipitant) is now commercially available across the United States for the ...
Vanda announced that NEREUS™ is now available for the prevention of vomiting induced by motion in adults, representing the first new prescription medicine approved for this condition in more than 40 ...
Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results